NCT03771651View on ClinicalTrials.gov

Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

May 6, 2022

Study Completion Date

June 30, 2025

Conditions
Fallopian Tube CancerFallopian Tube Infection
Interventions
DRUG

Aspirin 81 mg

Subjects will take aspirin daily for 14 days leading up to surgery to determine whether it impacts inflammation of fallopian tubes.

Trial Locations (1)

73117

Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER